Home > Boards > US Listed > Medical - Drugs > Ligand Pharmaceuticals Inc (LGND)

Sorry - hit send too fast - so

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
K The New Investor Member Profile
 
Followed By 1
Posts 13
Boards Moderated 0
Alias Born 07/28/16
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/23/2020 8:07:36 AM
Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Mill... Business Wire - 9/23/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/10/2020 4:44:37 PM
Ligand Expands OmniAb® Antibody Discovery Platform Through the Acquisitions of xCella Biosciences and Taurus Biosciences Business Wire - 9/10/2020 8:00:00 AM
Ligand Pharmaceuticals Management to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference Business Wire - 9/1/2020 4:02:00 PM
Ligand Commences Previously Announced Cash Tender Offer to Acquire Pfenex Inc. Business Wire - 8/31/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/25/2020 7:11:34 PM
Ligand OmniAb® Partner Immunovant Announced Positive Topline Results from Multicenter, Placebo-Controlled Phase 2a Trial of ... Business Wire - 8/25/2020 4:15:00 PM
Ligand Announces Amgen’s KYPROLIS® Approved by FDA as Combination Regimen with DARZALEX® & Dexamethasone in Once- & Twice... Business Wire - 8/24/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/11/2020 6:04:44 AM
Ligand to Acquire Pfenex Inc. Business Wire - 8/10/2020 5:36:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2020 5:28:33 PM
CStone Announces That OmniAb-derived CS1001 (Anti-PD-L1) Phase 3 Trial Met the Primary Endpoint as First-Line Treatment in St... Business Wire - 8/7/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/3/2020 7:49:19 AM
Ligand Reports Second Quarter 2020 Financial Results Business Wire - 8/3/2020 7:30:00 AM
Ligand’s Second Quarter Financial Results to be Reported August 3rd Business Wire - 7/16/2020 4:28:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/9/2020 4:28:46 PM
Sermonix Pharmaceuticals to Collaborate With Eli Lilly and Company in Studying Combination of Lasofoxifene and Lilly’s CDK ... GlobeNewswire Inc. - 7/8/2020 10:00:10 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 6/15/2020 1:43:42 PM
Ligand Announces an Expansion of Vernalis Collaboration with Servier for Research on Novel Oncology Targets Business Wire - 6/15/2020 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:47:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:36:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:35:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:35:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/12/2020 6:34:53 PM
K The New Investor   Tuesday, 08/09/16 02:23:58 PM
Re: None
Post # of 3529 
Sorry - hit send too fast - so partnering with Gilead is one reason...then once good news is over, ti falls - all depends who Ligarnd helps out. I see this stock swing easily $4 one wayo of the other every few days....Motley says a buy now - as it dropped from $138 last week back to $115 a share.

Any thougth son if you agree it is a bgood buy again - or will ligand continue to drop - thinking of adding shares - I bought at $120 - then it dropped....didn't expect a big drop like this
after good news wore off

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences